Anti-estrogenic agents might be more favorable option for treatment of hereditary hemorrhagic telangiectasia

Med Hypotheses. 2009 Feb;72(2):230-1. doi: 10.1016/j.mehy.2008.10.003. Epub 2008 Nov 28.
No abstract available

Publication types

  • Letter

MeSH terms

  • Estrogen Antagonists / metabolism
  • Estrogen Antagonists / therapeutic use*
  • Humans
  • Receptors, Estrogen / metabolism
  • Tamoxifen
  • Telangiectasia, Hereditary Hemorrhagic / drug therapy*

Substances

  • Estrogen Antagonists
  • Receptors, Estrogen
  • Tamoxifen